D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Director, Medical Writing

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeWaltham, MA, USA$190k - $235k

About the Job

Requirements

  • A bachelor's degree in life sciences or a related discipline is required; an advanced degree is preferred, with a strong understanding of biochemistry and molecular biology principles.
  • At least 10 years of medical writing experience in the pharmaceutical or biotechnology industry, including significant experience preparing clinical and regulatory documents.
  • Deep experience authoring and reviewing clinical and regulatory documents.
  • Ability to lead strategic discussions that align content and messaging across submissions.
  • Experience overseeing internal and external medical-writing resources, including vendors, consultants, and cross-functional contributors.
  • Demonstrated expertise writing, editing, and reviewing protocols, clinical study reports, investigator brochures, CTD modules, and other clinical regulatory documents.
  • Strong understanding of FDA and international regulations, ICH guidelines, and regulatory processes related to document preparation, production, and submission, including CTD requirements.
  • Experience developing and executing medical-writing strategy across programs, submissions, or therapeutic areas.
  • Proficiency with Microsoft Office, Adobe Acrobat, and shared document management systems such as SharePoint.
  • Ability to prioritize, manage multiple projects simultaneously, and deliver high-quality work under tight timelines.
  • Detailed knowledge of requirements for key clinical, nonclinical, and regulatory documents supporting INDs, CTAs, annual reports, and related submissions.
  • Strong attention to detail, accuracy, and consistency.
  • Ability to synthesize, analyze, and present complex clinical and scientific data clearly and accurately.
  • Ability to solve problems in a fast-paced, cross-functional environment.
  • Ability to integrate input from multiple contributors into clear, cohesive, submission-ready documents.

Responsibilities

  • Lead the planning, authoring, review, and completion of clinical and regulatory documents required for submissions to the FDA and other global health authorities.
  • Manage internal and external medical-writing resources to deliver accurate, high-quality documents on time and in accordance with established standards.
  • Author, edit, and collaborate with cross-functional team members on protocols, investigator brochures, clinical study reports, CTD modules, briefing books, and related submission materials.
  • Review and refine documents or document sections prepared by functional contributors to ensure quality, consistency, scientific accuracy, and adherence to company and regulatory standards.
  • Contribute to project planning and cross-functional working groups to support efficient development, review, approval, and finalization of submission-ready documents.
  • Establish and continuously improve medical-writing processes, templates, and best practices to increase quality, consistency, and operational efficiency.

Desired Qualifications

  • An advanced degree.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs